Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor β

Oncogene

Volumn 25, Issue 28, 2006, Pages 3982-3993

  Qiu, J ^a   Wong, J ^a   Tweardy, D J ^a   Dong, S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AML1; AML1 X; FRAP

Indexed keywords

CORE BINDING FACTOR; CORE BINDING FACTOR BETA; HYBRID PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AML1 GENE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LEUKEMOGENESIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; CELL COMPARTMENTATION; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; DIMERIZATION; GREEN FLUORESCENT PROTEINS; HUMANS; PROTEIN TRANSPORT; XENOPUS;

EID: 33745624285     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209431     Document Type: Article

References (30)

1. Adya N, Stacy T, Speck NA, Liu PP. (1998). Mol Cell Biol 18: 7432-7443.
2. Bangsow C, Rubins N, Glusman G, Bernstein Y, Negreanu V, Goldenberg D et al. (2001). Gene 279: 221-232.
3. Barseguian K, Lutterbach B, Hiebert SW, Nickerson J, Lian JB, Stein JL et al. (2002). Proc Natl Acad Sci USA 99: 15434-15439.
4. Davis JN, McGhee L, Meyers S. (2003). Gene 303: 1-10.
5. Dong S, Tweardy DJ. (2002). Blood 99: 2637-2646.
6. Dong S, Qiu J, Stenoien DL, Brinkley WR, Mancini MA, Tweardy DJ. (2003). Oncogene 22: 858-868.
7. Dong S, Stenoien DL, Qiu J, Mancini MA, Tweardy DJ. (2004). Mol Cell Biol 24: 4465-4475.
8. Francastel C, Magis W, Groudine M. (2001). Proc Natl Acad Sci USA 98: 12120-12125.
9. Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y et al. (1998). Blood 91: 4028-4037.
10. Harrington KS, Javed A, Drissi H, McNeil S, Lian JB, Stein JL et al. (2002). J Cell Sci 115: 4167-4176.
11. Hildebrand D, Tiefenbach J, Heinzel T, Grez M, Maurer AB. (2001). J Biol Chem 276: 9889-9895.
12. Hinojos CA, Sharp ZD, Mancini MA. (2005). Trends Endocrinol Metab 16: 12-18.
13. Hug BA, Lee SY, Kinsler EL, Zhang J, Lazar MA. (2002). Cancer Res 62: 2906-2912.
14. Korgaonkar C, Zhao L, Modestou M, Quelle DE. (2002). Mol Cell Biol 22: 196-206.
15. Licht JD. (2001). Oncogene 20: 5660-5679.
16. Lutterbach B, Hiebert SW. (2000). Gene 245: 223-235.
17. McNeil S, Zeng C, Harrington KS, Hiebert S, Lian JB, Stein JL et al. (1999). Proc Natl Acad Sci USA 96: 14882-14887.
18. Meyers S, Lenny N, Hiebert SW. (1995). Mol Cell Biol 15: 1974-1982.
19. Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S et al. (2000). Mol Cell 5: 811-820.
20. Misteli T. (2001). Science 291: 843-847.
21. Peterson LF, Zhang DE. (2004). Oncogene 23: 4255-4262.
22. So CW, Cleary ML. (2004). Blood 104: 919-922.
23. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA. (2000). Mol Endocrinol 14: 518-534.
24. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW et al. (2001). Nat Cell Biol 3: 15-23.
25. Stewart MD, Li J, Wong J. (2005). Mol Cell Biol 25: 2525-2538.
26. Tanaka K, Tanaka T, Kurokawa M, Imai Y, Ogawa S, Mitani K et al. (1998). Blood 91: 1688-1699.
27. Westendorf JJ, Hiebert SW. (1999). J Cell Biochem 75 (Suppl 32-33): 51-58.
28. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J. (2003). Mol Cell 12: 723-734.
29. Zaidi SK, Sullivan AJ, van Wijnen AJ, Stein JL, Stein GS, Lian JB. (2002). Proc Natl Acad Sci USA 99: 8048-8053.
30. Zhang J, Hug BA, Huang EY, Chen CW, Gelmetti V, Maccarana M et al. (2001). Mol Cell Biol 21: 156-163.